Treatment of Small Intestine Bacterial Overgrowth with Rifaximin, a Non-Absorbable Rifamycin
1988 ◽
Vol 16
(4)
◽
pp. 312-316
◽
Keyword(s):
In twelve patients affected by small bowel bacterial overgrowth, diagnosed by means of the lactulose hydrogen breath test, the therapeutic efficacy of a non-absorbable derivative of rifamycin, rifaximin, was evaluated. This study showed that this drug has a satisfactory therapeutic efficacy in contaminated small bowel syndrome and, at the doses tested, is free of side-effects.
1979 ◽
Vol 14
(3)
◽
pp. 333-336
◽
2009 ◽
Vol 44
(9)
◽
pp. 944-951
◽
Keyword(s):
Keyword(s):